• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • NORTH AMERICA EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • NORTH AMERICA EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Biotech Market
    Biotech News
    Biotech Stocks
    • Biotech Market
    • Biotech News
    • Biotech Stocks

    BioAmber Will Start Trading on the TSX

    Bryan Mc Govern
    May. 03, 2017 08:22AM PST
    Biotech Investing

    BioAmber announced it will begin trading on the TSX under the symbol BIOA starting May 3, 2017.

    BioAmber (NYSE:BIOA) announced it will officially be trading on the TSX under the symbol BIOA starting May 3, 2017.
    As quoted in the press release:

    BioAmber’s previously issued special warrant (the “Special Warrant“) was automatically exercised, on April 28, 2017, for 2,224,199 Common Shares (the “Underlying Shares“) following the issuance of a receipt for its final prospectus qualifying the Underlying Shares by the British Columbia Securities Commission.
    The Special Warrant was issued in a private placement on December 30, 2016, at a price of US$4.00 per Underlying Share issuable upon the exercise of the Special Warrant, resulting in gross proceeds to the Company of US$8,896,796. The proceeds were placed in escrow and were released to the Company concurrently with the automatic exercise of the Special Warrant.

    Click here to read the full press release.

    Source: www.newswire.ca

    private placementbritish columbia securitiesbritish columbia
    The Conversation (0)

    Go Deeper

    AI Powered
    tsx venture

    TSX Venture Exchange Stock Maintenance Bulletins

    ABVC BioPharma Receives Additional US$100,000 Licensing Payment from OncoX BioPharma, Bringing Total Payments to US$695,950

    Latest News

    Appendix 4C and Quarterly Activities Report - September 2025

    Nextech3D.ai Reports Strong 20% Q2 Sequential Revenue Growth With Gross Margins of 88% For the Three Months Ended September 30, 2025 ("Q2 2026")

    Nextech3D.ai Reports Milestone YTD Revenue Growth for AI Matchmaking in 2025 with a 95% Gross Margin

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
      • Electric Vehicles
    • Agriculture
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Energy
      • Uranium
      • Oil and Gas
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Robotics
      • Crypto
      • Cleantech
    Life Science
      • Biotech
      • Cannabis
      • Pharmaceuticals

    Featured Biotech Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES